These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30430940

  • 1. Anxiety Disorders: Sex Differences in Serotonin and Tryptophan Metabolism.
    Songtachalert T, Roomruangwong C, Carvalho AF, Bourin M, Maes M.
    Curr Top Med Chem; 2018; 18(19):1704-1715. PubMed ID: 30430940
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [Abstract] [Full Text] [Related]

  • 4. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
    Kanchanatawan B, Sirivichayakul S, Carvalho AF, Anderson G, Galecki P, Maes M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan 03; 80(Pt C):205-216. PubMed ID: 28690204
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer's Disease.
    Maes M, Anderson G.
    Curr Pharm Des; 2016 Jan 03; 22(8):1074-85. PubMed ID: 25547097
    [Abstract] [Full Text] [Related]

  • 7. IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.
    Chaves Filho AJM, Lima CNC, Vasconcelos SMM, de Lucena DF, Maes M, Macedo D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan 03; 80(Pt C):234-249. PubMed ID: 28595944
    [Abstract] [Full Text] [Related]

  • 8. Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity.
    Maes M, Galecki P, Verkerk R, Rief W.
    Neuro Endocrinol Lett; 2011 Jan 03; 32(3):264-73. PubMed ID: 21712776
    [Abstract] [Full Text] [Related]

  • 9. Chronic immune activation underlies morbid obesity: is IDO a key player?
    Brandacher G, Hoeller E, Fuchs D, Weiss HG.
    Curr Drug Metab; 2007 Apr 03; 8(3):289-95. PubMed ID: 17430117
    [Abstract] [Full Text] [Related]

  • 10. Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway.
    Roomruangwong C, Kanchanatawan B, Carvalho AF, Sirivichayakul S, Duleu S, Geffard M, Maes M.
    World J Biol Psychiatry; 2018 Apr 03; 19(3):200-209. PubMed ID: 27427239
    [Abstract] [Full Text] [Related]

  • 11. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer.
    Barreto FS, Chaves Filho AJM, de Araújo MCCR, de Moraes MO, de Moraes MEA, Maes M, de Lucena DF, Macedo DS.
    Behav Pharmacol; 2018 Apr 03; 29(2 and 3-Spec Issue):165-180. PubMed ID: 29543650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
    Almulla AF, Thipakorn Y, Vasupanrajit A, Tunvirachaisakul C, Oxenkrug G, Al-Hakeim HK, Maes M.
    Cells; 2022 Oct 02; 11(19):. PubMed ID: 36231075
    [Abstract] [Full Text] [Related]

  • 14. The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders.
    Morris G, Carvalho AF, Anderson G, Galecki P, Maes M.
    Curr Pharm Des; 2016 Oct 02; 22(8):963-77. PubMed ID: 26667000
    [Abstract] [Full Text] [Related]

  • 15. Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation.
    Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpé S.
    Life Sci; 2002 Sep 06; 71(16):1837-48. PubMed ID: 12175700
    [Abstract] [Full Text] [Related]

  • 16. Monitoring tryptophan metabolism in chronic immune activation.
    Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D.
    Clin Chim Acta; 2006 Feb 06; 364(1-2):82-90. PubMed ID: 16139256
    [Abstract] [Full Text] [Related]

  • 17. Etiological classification of depression based on the enzymes of tryptophan metabolism.
    Fukuda K.
    BMC Psychiatry; 2014 Dec 24; 14():372. PubMed ID: 25540092
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
    Anderson G, Jacob A, Bellivier F, Geoffroy PA.
    Curr Pharm Des; 2016 Dec 24; 22(8):987-1012. PubMed ID: 26654772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.